Current Understanding of the Role of PPARγ in Gastrointestinal Cancers

被引:7
|
作者
Zou, Bing [1 ]
Qiao, Liang [1 ,2 ]
Wong, Benjamin C. Y. [1 ]
机构
[1] Univ Hong Kong, Dept Med, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China
[2] Univ Sydney, Westmead Hosp, Dept Gastroenterol & Hepatol, Storr Liver Unit,Westmead Millennium Inst, Westmead, NSW 2145, Australia
关键词
ACTIVATED-RECEPTOR-GAMMA; INTESTINAL POLYP FORMATION; ALPHA/GAMMA DUAL AGONIST; ABERRANT CRYPT FOCI; COLON-CANCER; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); INHIBITS PROLIFERATION; DEPENDENT SUPPRESSION; LIGAND ROSIGLITAZONE; CELL-PROLIFERATION;
D O I
10.1155/2009/816957
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Numerous studies have indicated that PPAR gamma plays multiple roles such as in inflammation, cell cycle control, cell proliferation, apoptosis, and carcinogenesis, thus PPAR gamma contributes to the homeostasis. Many in vitro studies have showed that ligand-induced activation of PPAR gamma possess antitumor effect in many cancers including CRC. However, the role of PPAR gamma in gastrointestinal cancers, especially in colorectal cancer, is rather controversial. Nevertheless, some recent studies with the positive results on the possible application of PPAR gamma ligands, such as Bezafibrate or Rosiglitazone in gastrointestinal cancers, have suggested a potential usefulness of PPAR gamma agonists in cancer prevention and therapy. In this review, the authors discuss the recent developments in the role of PPAR. in gastrointestinal cancers. Copyright (C) 2009 Bing Zou et al.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] The role of the microbiome in drug resistance in gastrointestinal cancers
    Garajova, Ingrid
    Balsano, Rita
    Wang, Heling
    Leonardi, Francesco
    Giovannetti, Elisa
    Deng, Dongmei
    Peters, Godefridus J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (02) : 165 - 176
  • [32] The emerging role of caspase inhibitors in gastrointestinal cancers
    Katsuya Shiraki
    Koujiro Takase
    Takeshi Nakano
    Journal of Gastroenterology, 2002, 37 : 323 - 331
  • [33] The Role of the Hedgehog Pathway in Chemoresistance of Gastrointestinal Cancers
    Liang, Yabing
    Yang, Ling
    Xie, Jingwu
    CELLS, 2021, 10 (08)
  • [34] The role of fibronectin and nitric oxide (NO) in gastrointestinal cancers
    Hazar, B
    Polat, G
    Bagdatoglu, Ö
    Seyrek, E
    Tezcan, Y
    Kanik, A
    HEPATO-GASTROENTEROLOGY, 2005, 52 (61) : 119 - 122
  • [35] The Role of Gut Microbiota in Gastrointestinal Tract Cancers
    Grochowska, Marta
    Perlejewski, Karol
    Laskus, Tomasz
    Radkowski, Marek
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2022, 70 (01)
  • [36] Current Status and Future Perspective of Immunotherapy in Gastrointestinal Cancers
    Lu, Zhihao
    Peng, Zhi
    Liu, Chang
    Wang, Zhenghang
    Wang, Yakun
    Jiao, Xi
    Li, Jian
    Shen, Lin
    INNOVATION, 2020, 1 (02):
  • [37] Role of the microbiome in non-gastrointestinal cancers
    Pevsner-Fischer, Meirav
    Tuganbaev, Timur
    Meijer, Mariska
    Zhang, Sheng-Hong
    Zeng, Zhi-Rong
    Chen, Min-Hu
    Elinav, Eran
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2016, 7 (02): : 200 - 213
  • [38] Brain Metastases in Gastrointestinal Cancers: Is there a Role for Surgery?
    Lemke, Johannes
    Scheele, Jan
    Kapapa, Thomas
    von Karstedt, Silvia
    Wirtz, Christian Rainer
    Henne-Bruns, Doris
    Kornmann, Marko
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (09) : 16816 - 16830
  • [39] Current trends and perspectives in interventional radiology for gastrointestinal cancers
    Reitano, Elisa
    de'Angelis, Nicola
    Bianchi, Giorgio
    Laera, Letizia
    Spiliopoulos, Stavros
    Calbi, Roberto
    Memeo, Riccardo
    Inchingolo, Riccardo
    WORLD JOURNAL OF RADIOLOGY, 2021, 13 (10): : 314 - +
  • [40] Gastrointestinal cancers: current biomarkers in esophageal and gastric adenocarcinoma
    Dhakras, Purabi
    Uboha, Nataliya
    Horner, Vanessa
    Reinig, Erica
    Matkowskyj, Kristina A.
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 5